Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Baxter

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Clinical Endocrinology|May 29, 2002
The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 aloneGreet Van den Berghe, Robert C Baxter, Frank Weekers, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illnessDieter Mesotten, Pieter J Wouters, Robin P Peeters, et al.
Biopreservation and Biobanking|December 16, 2014
Factors that may influence the willingness of cancer patients to consent for biobankingUssha Pillai, Kathleen Phillips, Graham Wilkins, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct strictureChristopher J Scarlett, Alex J Saxby, AiQun Nielsen, et al.
The Journal of Urology|December 14, 2007
Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinomaShang-Tian Chuang, Kurt T Patton, Kristian T Schafernak, et al.
Scientific Reports|March 1, 2019
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)Wendy Ha, Hatice Sevim-Nalkiran, Ashraf M Zaman, et al.
Nature Clinical Practice. Oncology|April 24, 2008
Rapamycin treatment for a child with germline PTEN mutationDeborah J Marsh, Toby N Trahair, Janet L Martin, et al.
Clinical Chemistry|June 24, 2008
Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping testsTuan V Nguyen, Anne E Nelson, Christopher J Howe, et al.
Endocrine-Related Cancer|November 1, 2012
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cellsPatsy S H Soon, Edward Kim, Cindy K Pon, et al.
The Journal of Clinical Endocrinology and Metabolism|November 18, 2004
Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition settingMarie-Louise Healy, Rolf Dall, James Gibney, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Clinical Endocrinology|May 29, 2002
The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 aloneGreet Van den Berghe, Robert C Baxter, Frank Weekers, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illnessDieter Mesotten, Pieter J Wouters, Robin P Peeters, et al.
Biopreservation and Biobanking|December 16, 2014
Factors that may influence the willingness of cancer patients to consent for biobankingUssha Pillai, Kathleen Phillips, Graham Wilkins, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct strictureChristopher J Scarlett, Alex J Saxby, AiQun Nielsen, et al.
The Journal of Urology|December 14, 2007
Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinomaShang-Tian Chuang, Kurt T Patton, Kristian T Schafernak, et al.
Scientific Reports|March 1, 2019
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)Wendy Ha, Hatice Sevim-Nalkiran, Ashraf M Zaman, et al.
Nature Clinical Practice. Oncology|April 24, 2008
Rapamycin treatment for a child with germline PTEN mutationDeborah J Marsh, Toby N Trahair, Janet L Martin, et al.
Clinical Chemistry|June 24, 2008
Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping testsTuan V Nguyen, Anne E Nelson, Christopher J Howe, et al.
Endocrine-Related Cancer|November 1, 2012
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cellsPatsy S H Soon, Edward Kim, Cindy K Pon, et al.
The Journal of Clinical Endocrinology and Metabolism|November 18, 2004
Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition settingMarie-Louise Healy, Rolf Dall, James Gibney, et al.
Pageof 12